테크네튬 99m 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 용도별, 최종사용자별, 지역별

The Technetium-99m Market size was US$ 4.54 billion in 2024 and is expected to reach US$ 6.03 billion by 2031. The Technetium-99m market size is estimated to register a CAGR of 4.2% during 2025-2031.

The U.S. Technetium-99m market is expanding steadily, driven by advanced healthcare infrastructure, high patient awareness, and widespread adoption of nuclear medicine imaging. Hospitals and diagnostic centers are increasingly investing in hybrid imaging systems such as SPECT/CT to enhance diagnostic accuracy and workflow efficiency. The growing prevalence of cardiovascular diseases, cancer, and bone disorders is fueling demand for Tc-99m-based imaging across cardiology, oncology, and bone scans. Technological innovations, including cadmium-zinc-telluride (CZT) detectors and advanced reconstruction software, are further improving image quality, reducing scan times, and minimizing radiation exposure for patients. Strong Mo-99/Tc-99m generator supply chains ensure consistent availability of Tc-99m radiopharmaceuticals, supporting routine clinical use. In addition, ongoing research into novel tracers for tumor and neurological imaging is expected to expand clinical applications, reinforcing Tc-99m's dominance as the preferred diagnostic isotope in the U.S. healthcare market.

The Middle East and Africa (MEA) Technetium-99m (Tc-99m) market is emerging as a region of significant growth potential, driven by increasing investment in healthcare infrastructure, rising awareness of nuclear medicine, and growing prevalence of chronic diseases. Countries such as Saudi Arabia, UAE, South Africa, and Egypt are at the forefront, with governments actively supporting the adoption of advanced diagnostic technologies. Hospitals and diagnostic centers are expanding nuclear medicine capabilities to include hybrid imaging systems like SPECT/CT, improving diagnostic precision for cardiovascular, oncology, bone, and other organ-specific applications.

The rising burden of cardiovascular diseases, cancer, and respiratory disorders in the region is increasing demand for Tc-99m-based imaging procedures. Investments in healthcare infrastructure, particularly in private hospitals and specialized diagnostic centers, are supporting the installation of advanced imaging equipment. Additionally, collaborations with global suppliers and technology providers are helping regional facilities access the latest imaging innovations, including CZT detectors and advanced image reconstruction software.

Despite certain challenges such as high equipment costs and limited trained personnel, the MEA market is benefiting from growing government initiatives promoting healthcare modernization, including improved access to radiopharmaceuticals and enhanced regulatory support. The availability of reliable Mo-99/Tc-99m generators ensures consistent supply, enabling routine diagnostic use. With increasing patient awareness, healthcare investments, and adoption of modern imaging technologies, the MEA Technetium-99m market is expected to experience steady and sustained growth over the coming years.

Lantheus Holdings Inc; Curium; Jubilant Radiopharma; NorthStar Medical Radioisotopes, LLC; Sun RadioPharma (Sun Pharmaceutical Industries, Inc.); NTP Radioisotopes SOC Ltd; Cardinal Health Inc; Medi-Radiopharma; Eckert & Ziegler AG; and Isotope JSC are among the key Technetium-99m market players that are profiled in this market study.

The overall Technetium-99m market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the EMEA Technetium-99m market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the EMEA Technetium-99m market.

Table Of Contents

1. Executive Summary

• 1.1 Analyst Market Outlook
• 1.2 Market Attractiveness

2. Technetium-99m Market Landscape

• 2.1 Overview
• 2.2 Value Chain Analysis
  • 2.2.1 Raw Materials/Components
  • 2.2.2 Manufacturing Process/Technology
  • 2.2.3 Distribution Landscape
  • 2.2.4 End-User
  • 2.2.5 Level of Integration
• 2.3 PEST Analysis

3. Competitive Landscape

• 3.1 Company Benchmarking by Key Players
• 3.2 Market Share Analysis, 2024 - By Key Players
• 3.3 Market Concentration

4. Technetium-99m Market - Key Industry Dynamics

• 4.1 Technetium-99m Market - Key Industry Dynamics
• 4.2 Market Drivers
• 4.3 Market Restraints
• 4.4 Market Opportunities
• 4.5 Future Trends
• 4.6 Impact of Drivers and Restraints

5. Technetium-99m Market - Global Market Analysis

• 5.1 Technetium-99m Market Revenue (US$ Million), 2021-2031
• 5.2 Technetium-99m Market Forecast and Analysis

6. Technetium-99m Market Revenue Analysis - Application Areas

• 6.1 Overview
• 6.2 Technetium-99m Market Forecasts and Analysis by Application Areas
• 6.3 Cardiovascular
  • 6.3.1 Overview
  • 6.3.2 Cardiovascular Market Revenue, 2021-2031 (US$ Million)
• 6.4 Bone Scan
  • 6.4.1 Overview
  • 6.4.2 Bone Scan Market Revenue, 2021-2031 (US$ Million)
• 6.5 Respiratory
  • 6.5.1 Overview
  • 6.5.2 Respiratory Market Revenue, 2021-2031 (US$ Million)
• 6.6 Tumor Imaging
  • 6.6.1 Overview
  • 6.6.2 Tumor Imaging Market Revenue, 2021-2031 (US$ Million)
• 6.7 Others
  • 6.7.1 Overview
  • 6.7.2 Others Market Revenue, 2021-2031 (US$ Million)

7. Technetium-99m Market Revenue Analysis - End Users

• 7.1 Overview
• 7.2 Technetium-99m Market Forecasts and Analysis by End Users
• 7.3 Hospitals
  • 7.3.1 Overview
  • 7.3.2 Hospitals Market Revenue, 2021-2031 (US$ Million)
• 7.4 Diagnostic and Imaging Centers
  • 7.4.1 Overview
  • 7.4.2 Diagnostic and Imaging Centers Market Revenue, 2021-2031 (US$ Million)
• 7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others Market Revenue, 2021-2031 (US$ Million)

8. Technetium-99m Market - Geographical Analysis

• 8.1 North America
  • 8.1.1 North America Technetium-99m Market Overview
  • 8.1.2 North America: Technetium-99m Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • 8.1.3 North America: Technetium-99m Market - By Segmentation
    • 8.1.3.1 Application Areas
    • 8.1.3.2 End Users
  • 8.1.4 North America: Technetium-99m Market Breakdown by Countries
    • 8.1.4.1 United States Market
      • 8.1.4.1.1 United States: Technetium-99m Market Revenue and Forecasts, 2021-2031 (US$ Million)
      • 8.1.4.1.2 United States: Technetium-99m Market - By Segmentation
        • 8.1.4.1.2.1 Application Areas
        • 8.1.4.1.2.2 End Users
    • 8.1.4.2 Canada Market
    • 8.1.4.3 Mexico Market
• 8.2 Europe
  • 8.2.1 Germany
  • 8.2.2 France
  • 8.2.3 Italy
  • 8.2.4 Spain
  • 8.2.5 United Kingdom
  • 8.2.6 Rest of Europe
• 8.3 Asia-Pacific
  • 8.3.1 Australia
  • 8.3.2 China
  • 8.3.3 India
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 Rest of Asia-Pacific
• 8.4 Middle East and Africa
  • 8.4.1 South Africa
  • 8.4.2 Saudi Arabia
  • 8.4.3 U.A.E
  • 8.4.4 Rest of Middle East and Africa
• 8.5 South and Central America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Rest of South and Central America

9. Technetium-99m Market Industry Landscape

10. Technetium-99m Market - Key Company Profiles

• 10.1 Lantheus Holdings Inc
  • 10.1.1 Key Facts
  • 10.1.2 Business Description
  • 10.1.3 Products and Services
  • 10.1.4 Financial Overview
  • 10.1.5 SWOT Analysis
  • 10.1.6 Key Developments
• 10.2 Curium
• 10.3 Jubilant Radiopharma
• 10.4 NorthStar Medical Radioisotopes, LLC
• 10.5 Sun RadioPharma (Sun Pharmaceutical Industries, Inc.)
• 10.6 NTP Radioisotopes SOC Ltd
• 10.7 Cardinal Health Inc
• 10.8 Medi-Radiopharma
• 10.9 Eckert & Ziegler AG
• 10.10 Isotope JSC

11. Appendix

• 11.1 Glossary
• 11.2
• 11.4 Research Methodology and Approach
  • 11.4.1 Secondary Research
  • 11.4.2 Primary Research
  • 11.4.3 Market Estimation Approach
    • 11.4.3.1 Supply Side Analysis
    • 11.4.3.2 Demand Side Analysis
  • 11.4.4 Research Assumptions and Limitations
• 11.5 Meet Our Analysts
• 11.6 About The Insight Partners
• 11.7 Market Intelligence Cloud